A 63-year-old man who began using Ozempic in 2023 to treat his diabetes has shared his experience with the medication, highlighting its role in managing the condition. The drug, originally developed for type 2 diabetes, has gained attention for its off-label use in weight loss, though its primary purpose remains blood sugar control. His account offers insight into how patients navigate long-term use and potential side effects of the widely discussed treatment. The story examines the broader implications of Ozempic’s expanding applications beyond its approved medical purpose.
Todd Engel, 63, was first prescribed Ozempic in 2023 to help manage his diabetes.
